In last trading session, Galectin Therapeutics Inc (NASDAQ:GALT) saw 0.45 million shares changing hands with its beta currently measuring 0.83. Company’s recent per share price
During the last session, Galectin Therapeutics Inc (NASDAQ:GALT)’s traded shares were 0.52 million, with the beta value of the company hitting 0.83. At the end
During the last session, Galectin Therapeutics Inc (NASDAQ:GALT)’s traded shares were 1.1 million, with the beta value of the company hitting 0.83. At the end
In the last trading session, 5.97 million shares of the Galectin Therapeutics Inc (NASDAQ:GALT) were traded, and its beta was 0.76. Most recently the company’s
Galectin Therapeutics Inc (NASDAQ:GALT)’s traded shares stood at 1.7 million during the last session, with the company’s beta value hitting 0.80. At the close of
In the last trading session, 2.79 million Galectin Therapeutics Inc (NASDAQ:GALT) shares changed hands as the company’s beta touched 0.82. With the company’s per share
In recent trading session, Galectin Therapeutics Inc (NASDAQ:GALT) saw 5.28 million shares changing hands at last check today with its beta currently measuring 0.78. Company’s
In the last trading session, 1.68 million shares of the Galectin Therapeutics Inc (NASDAQ:GALT) were traded, and its beta was 0.71. Most recently the company’s
Galectin Therapeutics Inc (NASDAQ:GALT)’s traded shares stood at 0.44 million during the latest session, with the company’s beta value hitting 0.72. At the last check
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
